Biotech Distilled
Substack ↗
Subscribe
Subscribe
Substack ↗
About
Research
Areas
Modalities
Phases
Targets
Track record
Movers
The Lead Compound
Home
›
Targets
› CASQ2
CASQ2
(1 companies · 1 programs)
Companies with an active program directed at CASQ2.
Solid Biosciences Inc.
SLDB
SGT-501
— Catecholaminergic Polymorphic Ventricular Tachycardia
Phase 1